File

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV

Retrieved on: 
Wednesday, August 17, 2022 - 10:18pm

NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV).

Key Points: 
  • NEW YORK, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • The investigation concerns whether Inotiv and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Akso Health Group Receives Notice of Filing Delinquency From Nasdaq

Retrieved on: 
Wednesday, August 17, 2022 - 11:00am

BEIJING, Aug. 17, 2022 /PRNewswire/ -- Akso Health Group.

Key Points: 
  • BEIJING, Aug. 17, 2022 /PRNewswire/ -- Akso Health Group.
  • In accordance with Nasdaq Listing Rule 5250(c)(1), the Company has up to 60 calendar days to either cure the deficiency or to submit a plan to Nasdaq showing how it intends to regain compliance.
  • This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a notification of deficiency.
  • Akso Health Group Inc. (NASDAQ: AHG), formerly known as Xiaobai MaimaiInc., operates a social e-commerce platform in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products.

Bloom Energy Corporation Announces Pricing of $338.0 Million Public Offering of Class A Common Stock

Retrieved on: 
Wednesday, August 17, 2022 - 4:32am

Bloom Energy Corporation (NYSE: BE) today announced the pricing of its underwritten public offering of 13,000,000 shares of Class A common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions.

Key Points: 
  • Bloom Energy Corporation (NYSE: BE) today announced the pricing of its underwritten public offering of 13,000,000 shares of Class A common stock at a public offering price of $26.00 per share, before underwriting discounts and commissions.
  • All of the shares of common stock are being offered by Bloom Energy.
  • In addition, Bloom Energy has granted the underwriters a 30-day option to purchase up to an additional 1,950,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Bloom Energy, are expected to be $338.0 million, excluding any exercise of the underwriters option to purchase additional shares.

HIVE Announces Quarterly Revenue of $44.2 Million up 13% From The Same Quarter Last Year and Earnings for our 1st Quarter Ended June 30, 2022

Retrieved on: 
Wednesday, August 17, 2022 - 1:20am

As a result, our Bitcoin and Ethereum digital assets generate unrealized gains and losses each quarter.

Key Points: 
  • As a result, our Bitcoin and Ethereum digital assets generate unrealized gains and losses each quarter.
  • It is important that investors understand the differences in operating earnings or losses in addition to Mark-to-market paper gains and losses each quarter.
  • Depreciation, amortization, depletion, stock-based compensation, and asset impairments are common non-cash charges that reduce earnings but not cash flows.
  • HIVE had non-cash charges of approximately $118.7 million for the past quarter, like many other crypto mining stocks during the big decline in the quarter.

Graphex Group Limited Announces Pricing of Upsized $11.7 Million Public Offering and NYSE American Listing

Retrieved on: 
Wednesday, August 17, 2022 - 12:08am

EF Hutton, division of Benchmark Investments, LLC, is acting as sole book-running manager for the offering.

Key Points: 
  • EF Hutton, division of Benchmark Investments, LLC, is acting as sole book-running manager for the offering.
  • Graphex Group Limited is a Cayman Island company with principal and administrative offices in Hong Kong and subsidiary office in Royal Oak, Michigan.
  • Graphex possesses patents and utility models covering various technological, design, and processing applications in addition to trade secrets and technological expertise.
  • This press release contains statements that constitute "forward-looking statements," including with respect to the proposed public offering.

Reborn Coffee, Inc. Announces Closing of Upsized $7.2 Million Initial Public Offering

Retrieved on: 
Tuesday, August 16, 2022 - 9:26pm

Brea, California, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (Nasdaq: REBN) (Reborn, or the Company), a California-based retailer of specialty coffee, today announced the closing of its previously announced upsized initial public offering of 1,440,000 shares of its common stock at a public offering price of $5.00 per share, for aggregate gross proceeds of approximately $7.2 million before deducting underwriting discounts, commissions, and other offering expenses.

Key Points: 
  • Brea, California, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (Nasdaq: REBN) (Reborn, or the Company), a California-based retailer of specialty coffee, today announced the closing of its previously announced upsized initial public offering of 1,440,000 shares of its common stock at a public offering price of $5.00 per share, for aggregate gross proceeds of approximately $7.2 million before deducting underwriting discounts, commissions, and other offering expenses.
  • The Companys common stock began trading on the Nasdaq Capital Market on August 12, 2022, under the symbol REBN.
  • The Company intends to use the net proceeds from the offering to open new company-owned retail locations, develop a franchise program and for general corporate purposes.
  • This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds.

Palisade Bio Announces Closing of $13.8 Million Upsized Underwritten Public Offering and Full Exercise of Over-Allotment Option

Retrieved on: 
Tuesday, August 16, 2022 - 9:05pm

The price per share of common stock, Series 1 Warrant and Series 2 Warrant is $0.25.

Key Points: 
  • The price per share of common stock, Series 1 Warrant and Series 2 Warrant is $0.25.
  • The warrants will be exercisable beginning on the date of stockholder approval of the exercisability of the warrants under Nasdaq rules.
  • Ladenburg Thalmann & Co. Inc. acted as sole book-running manager in connection with this offering.
  • Palisade Bio is a late-stage biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier.

Citizens Financial Group Announces Redemption of Subordinated Notes

Retrieved on: 
Tuesday, August 16, 2022 - 9:15pm

Citizens Financial Group, Inc. (NYSE: CFG) today announced the redemption on September 29, 2022, of all of its outstanding 6.50% Fixed-to-Floating Rate Subordinated Notes due October 1, 2027 (CUSIP No.

Key Points: 
  • Citizens Financial Group, Inc. (NYSE: CFG) today announced the redemption on September 29, 2022, of all of its outstanding 6.50% Fixed-to-Floating Rate Subordinated Notes due October 1, 2027 (CUSIP No.
  • The redemption price for the Notes will be equal to 100% of principal amount of the Notes redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date of September 29, 2022.
  • In accordance with the Notes, the holders of the Notes will receive notice of the redemption, the redemption price and further instructions and details related to the process of such redemption.
  • Citizens Financial Group, Inc. is one of the nations oldest and largest financial institutions, with $226.7 billion in assets as of June 30, 2022.

APPOINTMENT OF MANDY JOHNSTON TO THE BOARD OF DIRECTORS OF METALLA ROYALTY

Retrieved on: 
Tuesday, August 16, 2022 - 9:45pm

Brett Heath, President, and CEO of Metalla, commented, "On behalf of the Board of Directors and management, I would like to welcome Mandy to the Metalla board.

Key Points: 
  • Brett Heath, President, and CEO of Metalla, commented, "On behalf of the Board of Directors and management, I would like to welcome Mandy to the Metalla board.
  • We believe that Mrs. Johnston's valuable skillset and expertise will be a positive contribution to Metalla as we continue our evolution into a premier precious metals royalty company."
  • Mandy Johnston holds a Bachelor of Accounting (Honours) Co-op degree from Brock University.
  • In accordance with the Company's Share Compensation Plan, Metalla has granted 605,000 stock options to certain officers, directors, employees and consultants to purchase 605,000 common shares.

Biocept Announces a Delay in the Filing of its Quarterly Report on Form 10-Q

Retrieved on: 
Tuesday, August 16, 2022 - 1:00pm

(Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces a delay in the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.

Key Points: 
  • (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces a delay in the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.
  • At this time, the duration of the delay in the Form 10-Q filing cannot be reasonably estimated.
  • Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers.
  • Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.